Plants with Superpowers (GMO) Webinar

Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell, Inc. a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the successful launch of an open, livestream webinar series designed to inform and educate the public on the benefits and applications of stem cell therapy.

Circular, Rep-encoding single-stranded (CRESS) DNA viruses were once thought to be a rare kind of viral genomic architecture. While some significant agricultural diseases were caused by circoviruses and geminiviruses, they are not typically human pathogens, and it was only when metagenomic methods that were not biased towards double-stranded DNA were widely used did we identify single-stranded DNA viruses ubiquitously.

In November of 2019, the City and County of San Diego officially proclaimed “mRNA Day” to honor the grand opening of the TriLink BioTechnologies facility and Maravai LifeSciences headquarters. We’re carrying the torch forward to establish a tradition of celebrating mRNA by bringing together leaders in the industry to share their scientific knowledge, research expertise, and predictions for the future.

Today, cost pressure, market uncertainty, and market growth challenge the existing manufacturing technologies. With the rise of these more complex molecules often comes the challenge of manufacturing them cost-effective. One of the approaches that contract manufacturing organizations and drug development companies take to increase their manufacturing output is utilizing perfusion and process-intensive technologies. One of the challenges in such efforts is the adaptation of cells to very different culture conditions, which requires a sufficiently flexible cell and a good understanding of process requirements to maximize performance.